Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Statement of Changes in Stockholders Equity (Deficiency) (Unaudited)

v3.19.1
Condensed Interim Consolidated Statement of Changes in Stockholders Equity (Deficiency) (Unaudited) - USD ($)
Common Shares [Member]
Additional Paid-In Capital [Member]
Shares To Be Issued [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive loss [Member]
Total
Beginning Balance at Nov. 30, 2017 $ 93,014 $ 31,365,097   $ (31,098,864) $ (32,624) $ 326,623
Beginning Balance (Shares) at Nov. 30, 2017 93,014,134          
Stock based compensation   16,734       16,734
Shares to be issued     $ 112,500     112,500
Net loss for the period       (355,712)   (355,712)
Foreign currency translation         (574) (574)
Ending Balance at Feb. 28, 2018 $ 93,014 31,381,831 $ 112,500 (31,454,576) (33,198) 99,571
Ending Balance (Shares) at Feb. 28, 2018 93,014,134          
Beginning Balance at Nov. 30, 2018 $ 101,977 33,341,695   (33,252,338) (34,297) 157,037
Beginning Balance (Shares) at Nov. 30, 2018 101,976,900          
Stock based compensation   123,667       123,667
Shares issued for services $ 1,117 164,355       165,472
Shares issued for services (Shares) 1,116,542          
Net loss for the period       (883,772)   (883,772)
Foreign currency translation         (3,740) (3,740)
Ending Balance at Feb. 28, 2019 $ 103,094 $ 33,629,717   $ (34,136,110) $ (38,037) $ (441,336)
Ending Balance (Shares) at Feb. 28, 2019 103,093,442